Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2003
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018634A1 Monoclonal antibody cb874 directed to an unknown antigen from umbilical cord blood
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018596A2 Method for removing endotoxins from protein solutions
03/06/2003WO2003018056A1 Stabilized preparations containing antibody
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017817A2 Diagnosis, prevention and treatment of cancer
03/06/2003WO2003017780A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003WO2003000729A3 Secreted polypeptide and their use in the treatment of bone disorders
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002083171A3 Cancer treatment by using fap-alpha specific antibodies
03/06/2003WO2002083068A8 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
03/06/2003WO2002076578A9 Control of glycoforms in igg
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002066515B1 Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2002055106A3 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002045742A8 Lipoteichoic acid immunogenic compositions and methods of making and using thereof
03/06/2003WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof
03/06/2003WO2002033083A3 Methods of using a human il-17-related polypeptide to treat disease
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002030982A3 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
03/06/2003WO2002028481A3 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/06/2003WO2002026947A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002020735A3 Enzymes having high temperature polymerase activity and methods of use thereof
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002000914A9 Bioengineered vehicles for targeted nucleic acid delivery
03/06/2003WO2001098361A9 Agonist anti-trk-c monoclonal antibodies
03/06/2003WO2001098358A9 Compositions for identification and isolation of stem cells
03/06/2003WO2001092525A8 Compositions and methods for the therapy and diagnosis of lung cancer
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001080880A8 Apoptotic agents
03/06/2003WO2001072781A9 Human genes and expression products
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030045703 Novel forms of T cell costimulatory molecules and uses therefor
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045691 Reshaped human anti-hm 1.24 antibody
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045684 Polypeptide for use in humans therapeutics and diagnostics
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045681 Antibody for use in the treatment of angiogenesis
03/06/2003US20030045679 Peptide for use in the treatment of cancer and alzheimer's disease
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030044975 Cytokine-binding domain for use in the treatment of asthma and thrombocytopenia
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044958 Nucleotide sequences coding polypeptide for use in monitoring and treating inflammatory disorders
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044912 KCNQ potassium channels and methods of modulating same
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044909 Modulator of melatonin binding for use in the treatment of circadian rythm disorders
03/06/2003US20030044902 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of skin and tumor disorders
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044867 Receptor for a bacillus thuringiensis toxin
03/06/2003US20030044863 Diagnosing cancer in humans; obtain tissue sample, detect invasive complexes associated tissus, evaluate for cancer
03/06/2003US20030044859 Reagents and methods useful for detecting diseases of the breast
03/06/2003US20030044858 Anti-IgE antibodies
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044849 Methods for screening monoclonal antibodies on heterogeneous antigen substrates
03/06/2003US20030044848 Immunoaffinity isolation of modified peptides from complex mixtures
03/06/2003US20030044844 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044842 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044841 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044831 Antibody for use in the generation and protection of preferential nucleotide sequences
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044806 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
03/06/2003US20030044792 Methods and materials relataing to novel stem cell growth factor-like polypeptides and polynucleotides
03/06/2003US20030044788 Detection of modulators or kinase activity; obtain sample containing kinase, incubate with modulators, monitor adjustment in enzyme activity, adjustment in activity indicates modulator
03/06/2003US20030044783 Human genes and gene expression products
03/06/2003US20030044770 Methods for using resonance energy transfer- based assay of hiv-1 envelope gylcoprotein-mediated membrane fusion, and kits for practicing same
03/06/2003US20030044423 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype
03/06/2003US20030044420 Polypeptide self-antigen useful in tumor-specific vaccine mimics epitopes of antigen uniquely expressed by cells of the tumor; polypeptide is preferably produced in plant transformed or transfected with nucleic acid encoding the polypeptide
03/06/2003US20030044417 Self antigen vaccines for treating B cell lymphomas and other cancers
03/06/2003US20030044416 Nucleic acids encoding cd100 molecules
03/06/2003US20030044412 Membrane estrogen receptor-directed therapy in breast cancer
03/06/2003US20030044411 Complexing cytokines with epitopes
03/06/2003US20030044410 Neutralization interferons, tumor necrosis factor
1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 1494